-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Targeted therapies for fragile X syndrome: current state and future direction of clinical trials in humans
Christoph Kamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Targeted therapies for fragile X syndrome: current state and future direction of clinical trials in humans
Christoph Kamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Targeted therapies for fragile X syndrome: current state and future direction of clinical trials in humans
Christoph Kamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Targeted therapies for fragile X syndrome: current state and future direction of clinical trials in humans
Christoph Kamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Targeted therapies for fragile X syndrome: current state and future direction of clinical trials in humans
Christoph Kamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Targeted therapies for fragile X syndrome: current state and future direction of clinical trials in humans
Christoph Kamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Targeted therapies for fragile X syndrome: current state and future direction of clinical trials in humans
Christoph Kamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Targeted therapies for fragile X syndrome: current state and future direction of clinical trials in humans
Christoph Kamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation